Introduction
Methods
Participants
Measures
Analysis
Results
Employed | Fully work-disabled |
P
| |||
---|---|---|---|---|---|
n
| % |
n
| % | ||
Socio-demographic characteristics | |||||
Sex | |||||
Male | 168 | 48.7 | 66 | 38.7 | 0.02 |
Female | 177 | 51.3 | 104 | 61.3 | |
Age, mean (SD) | 44.2 (10.2) | 52.4 (8.6) | <0.001 | ||
Educational level | |||||
Low | 127 | 39.0 | 115 | 71.9 | <0.001 |
Middle | 99 | 30.4 | 32 | 20.2 | |
High | 99 | 30.6 | 12 | 7.8 | |
Illness characteristics | |||||
Duration (in years) since diagnosis, mean (SD) | 8.3 (8.8) | 10.3 (11.0) | 0.02 | ||
Presence of comorbidity (%) | 54 | 15.7 | 49 | 28.7 | 0.001 |
Work characteristics | |||||
Hours of work/week, mean (SD) | 35 (11) |
Employed | Fully work-disabled | |||||
---|---|---|---|---|---|---|
Medical health statusa
| Range | Mean | SD | Mean | SD |
P
|
Life-threatening | 1–3 | 1.14 | 0.39 | 1.35 | 0.56 | <0.001 |
Progressive deterioration | 1–3 | 1.40 | 0.64 | 1.77 | 0.73 | <0.001 |
Changing in course | 1–3 | 1.99 | 0.85 | 1.81 | 0.79 | 0.017 |
Controllability by medical care | 1–3 | 2.20 | 0.79 | 2.05 | 0.76 | 0.029 |
Self-reported health |
N
| % |
N
| % |
P
| |
---|---|---|---|---|---|---|
Functional limitations | ||||||
None | 218 | 64.04 | 18 | 12.21 | <0.001 | |
Light | 79 | 23.12 | 24 | 16.67 | ||
Moderate | 35 | 10.30 | 56 | 39.16 | ||
Severe | 9 | 2.54 | 46 | 31.96 |
Self-reported health | Range | Mean | SD | Mean | SD |
P
|
---|---|---|---|---|---|---|
Fatiguea
| 1–3 | 1.94 | 0.71 | 2.65 | 0.51 | <0.001 |
Paina
| 1–3 | 1.55 | 0.71 | 2.38 | 0.70 | <0.001 |
Illness perceptionsa
| Range | Mean | SD | Mean | SD |
P
|
---|---|---|---|---|---|---|
Consequences | 1–5 | 2.53 | 0.80 | 3.68 | 0.78 | <0.001 |
Chronic timeline | 1–5 | 4.27 | 0.76 | 4.43 | 0.62 | 0.027 |
Cyclical timeline | 1–5 | 3.06 | 0.95 | 3.40 | 0.96 | <0.001 |
Treatment control | 1–5 | 3.18 | 0.66 | 2.58 | 0.75 | <0.001 |
Personal control | 1–5 | 3.20 | 0.78 | 2.83 | 0.81 | <0.001 |
Coherence | 1–5 | 4.00 | 0.75 | 3.64 | 0.91 | <0.001 |
Causal dimensions | ||||||
Psychological attributions | 1–5 | 1.97 | 0.82 | 2.22 | 0.92 | 0.004 |
Risk factors | 1–5 | 1.98 | 0.70 | 2.00 | 0.66 | 0.851 |
Immunity | 1–5 | 2.10 | 0.87 | 2.18 | 0.84 | 0.365 |
Fully work-disabled (reference: employed) | |||
---|---|---|---|
Model 1: Block 1 + 2 | Model 2: Block 1 + 2 + 3 | Model 3: Block 1 + 2 + 3 + 4 | |
R2 = 38.2% | R2 = 65.4%a | R2 = 77.4%a | |
OR (95% CI) | OR (95% CI) | OR (95% CI) | |
1a. Socio-demographic characteristics | |||
Age |
1.08 (1.05–1.11)
|
1.07 (1.03–1.12)
|
1.08 (1.01–1.14)
|
Female (reference: male) |
3.33 (1.98–5.59)
|
3.00 (1.33–6.80)
|
5.33 (1.64–17.36)
|
Level of education (reference: low) | |||
Middle |
0.57 (0.32–1.02)
|
0.45 (0.18–1.10)
| 0.32 (0.09–1.15) |
High |
0.20 (0.10–0.42)
|
0.21 (0.07–0.57)
|
0.20 (0.05–0.79)
|
1b. Illness characteristics | |||
Time since diagnosis | 1.00 (0.98–1.03) | 0.99 (0.94–1.04) | 0.98 (0.91–1.05) |
Presence of comorbidity (reference: absence) | 1.70 (0.96–3.01) | 2.04 (0.86–4.85) | 3.45 (0.98–12.14) |
2. Medical health status | |||
Life-threatening | 1.62 (0.84–3.11) | 3.09 (1.00–9.53) | 2.80 (0.54–14.60) |
Progressive deterioration |
2.80 (1.68–4.69)
| 1.67 (0.77–3.64) | 2.48 (0.85–7.25) |
Changing course | 0.78 (0.48–1.28) | 1.13 (0.52–2.43) | 1.07 (0.33–3.41) |
Controllability by medical care | 0.70 (0.42–1.15) | 0.86 (0.38–1.91) | 0.80 (0.24–2.61) |
3. Self-reported health | |||
Functional limitations (reference: none) | |||
Light | 3.15 (1.09–9.06) | 4.31 (0.93–19.87) | |
Moderate |
11.94 (4.06–35.10)
|
14.27 (2.90–70.23)
| |
Severe |
49.47 (11.55–211.87)
|
21.92 (2.78–172.61)
| |
Fatigue |
2.42 (1.11–5.29)
| 1.65 (0.56–4.87) | |
Pain | 1.56 (0.66–3.70) | 1.79 (0.55–5.79) | |
4. Illness perceptions | |||
Consequences |
5.34 (2.31–12.34)
| ||
Chronic timeline | 0.76 (0.29–2.03) | ||
Cyclical timeline | 1.19 (0.62–2.26) | ||
Treatment control | 0.48 (0.20–1.17) | ||
Personal control | 0.91 (0.42–1.99) | ||
Coherence | 1.38 (0.69–2.75) | ||
Causal dimensions | |||
Psychological attributions | 1.85 (0.91–3.77) | ||
Risk factors | 0.98 (0.34–2.86) | ||
Immunity | 1.05 (0.54–2.04) |